Hyperthermic nanomedicines are particularly relevant for tackling human cancer, providing
a valuable alternative to conventional therapeutics. The early-stage preclinical performance …

As one of the main threats to human life (the fourth most dangerous and prevalent cancer),
colorectal cancer affects many people yearly, decreases patients' quality of life, and causes …

Both β-catenin and STAT3 drive colorectal cancer (CRC) growth, progression, and immune
evasion, and their co-overexpression is strongly associated with a poor prognosis. However …

Summary CMS4 colorectal cancer (CRC), based on the consensus molecular subtype
(CMS), stratifies patients with the poorest disease-free survival rates. It is characterized by a …

Fusobacterium nucleatum (Fn) has been extensively studied for its connection to colorectal
cancer (CRC) and its potential role in chemotherapy resistance. Studies indicate that Fn is …

Over the past decade, our understanding of the diversity of colorectal cancer has expanded
significantly, raising hopes of tailoring treatments more precisely for individual patients. A …

Colorectal cancer (CRC) is a complex disease with diverse etiologies and clinical outcomes.
Despite considerable progress in development of CRC therapeutics, challenges remain …

Background Near-pathological complete response (Near-pCR) patients constitute a distinct
subgroup with limited research attention. The clinical relevance of adjuvant chemotherapy …

Therapy resistance is attributed to over 80% of cancer deaths per year emphasizing the
urgent need to overcome this challenge for improved patient outcomes. Despite its …